J 2020

Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002–2017)

JABANDŽIEV, Petr, Tereza PINKASOVÁ, Lumír KUNOVSKÝ, Jan PAPEŽ, Martin JOUZA et. al.

Basic information

Original name

Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002–2017)

Authors

JABANDŽIEV, Petr (203 Czech Republic, guarantor, belonging to the institution), Tereza PINKASOVÁ (203 Czech Republic, belonging to the institution), Lumír KUNOVSKÝ (203 Czech Republic, belonging to the institution), Jan PAPEŽ (203 Czech Republic, belonging to the institution), Martin JOUZA (203 Czech Republic), Bára KARLÍNOVÁ (203 Czech Republic), Martina NOVÁČKOVÁ (203 Czech Republic), Milan URÍK (703 Slovakia, belonging to the institution), Štefánia AULICKÁ (703 Slovakia, belonging to the institution), Ondřej SLABÝ (203 Czech Republic, belonging to the institution), Júlia BOHOŠOVÁ (703 Slovakia, belonging to the institution), Kateřina BAJEROVÁ (203 Czech Republic), Milan BAJER (203 Czech Republic) and Ajay GOEL (840 United States of America)

Edition

Journal of Pediatric Gastroenterology and Nutrition, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2020, 0277-2116

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30209 Paediatrics

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.839

RIV identification code

RIV/00216224:14110/20:00118600

Organization unit

Faculty of Medicine

UT WoS

000561373900015

Keywords in English

children; Crohn disease; Czech Republic; incidence; inflammatory bowel disease; ulcerative colitis

Tags

International impact, Reviewed
Změněno: 26/2/2021 12:15, Mgr. Tereza Miškechová

Abstract

V originále

Objectives: Inflammatory bowel disease (IBD) is today a global disease, the incidence of which is growing in the pediatric population. This prospective study aims to decipher IBD incidence and its trend in a pediatric population through 16 years in the South Moravian Region of the Czech Republic. Methods: We evaluated data concerning 358 pediatric patients with newly diagnosed IBD at University Hospital Brno, which is a gastroenterology center for the entire pediatric population (0-18 years) and cares for all pediatric IBD patients in the South Moravian Region (1,187,667 inhabitants). Results: The study encompassed 3,488,907 children during 16 years. We diagnosed 192 children (53.6%) with Crohn disease (CD), 123 (34.4%) with ulcerative colitis (UC), and 43 (12.0%) with IBD-unclassified (IBD-U). The incidence of IBD increased from 3.8 (CD 2.9, UC 0.9, and IBD-U 0.0) per 100 000/year in 2002 to 14.7 (CD 9.8, UC 4.0, and IBD-U 0.9) per 100,000/year in 2017 (P < 0.001). The overall IBD incidence per 100,000/year was 9.8 (95% confidence interval [CI]: 8.8--10.9). Constituent incidences per 100,000/year were CD 5.2 (95% CI: 4.5--6.0), UC 3.4 (95% CI: 2.8--4.0), and IBD-U 1.2 (95% CI: 0.9--1.6). IBD incidence was projected to reach 18.9 per 100,000/year in 2022. Conclusions: The overall incidence of pediatric IBD in the Czech Republic is increasing, and especially that of CD, whereas trends in UC and IBD-U appear to be constant. These data highlight the need to identify risk factors involved in the rising incidence of IBD.

Links

NV17-29389A, research and development project
Name: Sekvenční FDG-PET a miRNA jako biomarker změny strategie předoperační léčby u lokálně pokročilého karcinomu žaludku a gastroesofageální junkce